| 18F-DOPA | 3,4-dihydroxy-6-[18F]fluoro-L-phenylalanine |
| ADC | Apparent diffusion coefficient |
| AGI | Artificial general intelligence |
| AI | Artificial intelligence |
| ANN | Artificial neural network |
| APOLLO | Raman-based pathology of malignant glioma |
| AR | Augmented reality |
| ATRX | Alpha-thalassemia/mental retardation X-linked |
| AUC | Area under curve |
| AURORA | A multicenter analysis of stereotactic radiotherapy to the resection cavity of brain metastases |
| BBB | Blood-brain barrier |
| BCRP | Breast cancer resistance protein |
| BraTumIA | Brain tumor image analysis |
| CAR | Chimeric antigen receptor |
| CBF | Cerebral blood flow |
| CDKN2A/B | Cyclin-dependent kinase inhibitor 2A/B |
| CET | Contrast-enhancing tumor |
| CFD | Cell fate determinant |
| Cho | Choline |
| CIC | Capicua transcriptional repressor |
| CMRO2 | Cerebral metabolic rate of oxygen |
| CNN | Convolutional neural network |
| CNS | Central nervous system |
| CPH | Cox proportional hazards |
| Cr | Creatine |
| CT | Computed tomography |
| CTL | Cytotoxic T-lymphocyte |
| CTV | Clinical target volume |
| DL | Deep learning |
| DSC | Dice similarity coefficient |
| DSC | Dynamic susceptibility contrast |
| DTI | Diffusion-tensor imaging |
| DWI | Diffusion-weighted imaging |
| EGFR | Epidermal growth factor receptor |
| FDG | 18F-fluorodeoxyglucose |
| FLAIR | Fluid-attenuated inversion recovery |
| FPR3 | N-formyl peptide receptor 3 |
| GBM | Glioblastoma multiforme |
| G-CIMP | Cytosine-phosphate-guanine island methylator phenotype |
| GPT-3 | Generative pre-trained transformer 3 |
| Grad-CAM | Gradient-weighted class activation mapping |
| GRS | Glycolysis-related gene signature |
| GTV | Gross tumor volume |
| HDFT-F | High-definition fiber tractography with sodium fluorescein |
| HSI | Hyperspectral imaging |
| HUD | Head-up display |
| IBM | International Business Machines Corporation |
| ICI | Immune checkpoint inhibitor |
| iDC-APC | Induced antigen-presenting cells |
| IDH1 | Isocitrate dehydrogenase 1 |
| IL-6 | Interleukin 6 |
| IM | Immune subtype |
| IMRT | Intensity-modulated radiation therapy |
| KPS | Karnofsky performance status |
| kVCT | Kilovoltage computed tomography |
| Lac | Lactate |
| LF | Local failure |
| LORIS | Logistic regression-based immunotherapy-response score |
| LSTM | Long short-term memory |
| mAR | Mobile augmented reality |
| MGMT | O[6]-methylguanine-DNA methyltransferase |
| MIL | Multi-instance learning |
| mitoPO2 | Tissue oxygen saturation |
| ML | Machine learning |
| MR | Mixed reality |
| MRI | Magnetic resonance imaging |
| MRPM | Magnetic resonance projection mapping |
| MRS | Magnetic resonance spectroscopy |
| NAA | N-acetylaspartate |
| NET2 | Non-enhancing T2 hyperintense |
| NK | Natural killer |
| NLP | Natural language processing |
| NLU | Natural language understanding |
| OEF | Oxygen extraction fraction |
| OS | Overall survival |
| PCNSL | Primary central nervous system lymphoma |
| PD1 | Programmed cell death protein 1 |
| PET | Positron emission tomography |
| PFS | Progression-free survival |
| P-gp | P-glycoprotein |
| RANO | Response assessment in neuro-oncology |
| rCBV | Relative cerebral blood volume |
| ROC | Receiver operating characteristic |
| ROI | Region of interest |
| RSF | Random survival forest |
| RS-fMRI | Resting-state functional magnetic resonance imaging |
| SHAP | Shapley additive explanations |
| SINA | Sina intraoperative neurosurgical assist |
| SRMA | Systematic review and meta-analysis |
| SRT | Stereotactic radiation therapy |
| SVM | Support vector machine |
| T1GD | T1-weighted gadolinium-enhanced |
| TCGA | The Cancer Genome Atlas |
| TCIA | The Cancer Imaging Archive |
| TERT | Telomerase reverse transcriptase |
| TERTp | Telomerase reverse transcriptase gene promoter |
| TME | Tumor microenvironment |
| TMZ | Temozolomide |
| TP53 | Tumor protein 53 |
| TRIPOD | Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis |
| TVN | Trans-visible navigator |
| ViT | Vision transformer |
| VNIR | Visible and near-infrared |
| VR | Virtual reality |
| WHO | World Health Organization |
| WSI | Whole-slide image |
| WSL | Weakly supervised learning |
| XAI | Explainable artificial intelligence |